CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Repro Med Systems, Inc. - KRMD CFD

2.39
6.22%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.09
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

KORU Medical Systems Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 2.25
Open* 2.22
1-Year Change* -46.25%
Day's Range* 2.22 - 2.41
52 wk Range 1.82-4.48
Average Volume (10 days) 44.58K
Average Volume (3 months) 972.01K
Market Cap 169.68M
P/E Ratio -100.00K
Shares Outstanding 45.61M
Revenue 29.04M
EPS -0.19
Dividend (Yield %) N/A
Beta 0.41
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 27, 2024 2.25 0.14 6.64% 2.11 2.25 2.11
Mar 26, 2024 2.13 -0.07 -3.18% 2.20 2.22 2.09
Mar 25, 2024 2.18 0.09 4.31% 2.09 2.20 2.09
Mar 22, 2024 2.09 -0.04 -1.88% 2.13 2.15 2.07
Mar 21, 2024 2.12 -0.10 -4.50% 2.22 2.28 2.08
Mar 20, 2024 2.24 0.21 10.34% 2.03 2.28 2.03
Mar 19, 2024 2.04 -0.01 -0.49% 2.05 2.08 2.01
Mar 18, 2024 2.06 -0.13 -5.94% 2.19 2.22 2.02
Mar 15, 2024 2.18 0.08 3.81% 2.10 2.30 2.10
Mar 14, 2024 2.17 0.09 4.33% 2.08 2.23 2.08
Mar 13, 2024 2.09 0.06 2.96% 2.03 2.10 2.03
Mar 12, 2024 2.05 -0.03 -1.44% 2.08 2.09 2.03
Mar 11, 2024 2.08 -0.05 -2.35% 2.13 2.18 2.03
Mar 8, 2024 2.17 0.04 1.88% 2.13 2.18 2.06
Mar 7, 2024 2.15 0.02 0.94% 2.13 2.15 2.05
Mar 6, 2024 2.13 0.10 4.93% 2.03 2.15 2.03
Mar 5, 2024 2.02 -0.05 -2.42% 2.07 2.08 2.00
Mar 4, 2024 2.06 -0.03 -1.44% 2.09 2.10 2.01
Mar 1, 2024 2.09 -0.04 -1.88% 2.13 2.14 2.06
Feb 29, 2024 2.10 -0.04 -1.87% 2.14 2.15 2.09

Repro Med Systems, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 27.896 23.4902 24.1765 23.1626 17.3537
Revenue 27.896 23.4902 24.1765 23.1626 17.3537
Cost of Revenue, Total 12.5271 9.7206 9.24036 8.30881 6.54325
Gross Profit 15.369 13.7696 14.9361 14.8538 10.8105
Total Operating Expense 38.6769 30.5197 25.4312 22.5769 16.1892
Selling/General/Admin. Expenses, Total 20.6065 17.8623 12.0283 9.77174 9.09557
Research & Development 4.95622 2.47367 1.29675 0.74048 0.24112
Depreciation / Amortization 0.58714 0.46313 0.4186 0.34023 0.30926
Operating Income -10.7809 -7.02953 -1.25478 0.58568 1.16454
Interest Income (Expense), Net Non-Operating 0.10572 -0.01583 0.04394 0.06291 0.00748
Net Income Before Taxes -10.6752 -6.36444 -1.19426 0.69642 1.17695
Net Income After Taxes -8.66114 -4.56282 -1.21206 0.56435 0.91057
Net Income Before Extra. Items -8.66114 -4.56282 -1.21206 0.56435 0.91057
Net Income -8.66114 -4.56282 -1.21206 0.56435 0.91057
Income Available to Common Excl. Extra. Items -8.66114 -4.56282 -1.21206 0.56435 0.91057
Income Available to Common Incl. Extra. Items -8.66114 -4.56282 -1.21206 0.56435 0.91057
Diluted Net Income -8.66114 -4.56282 -1.21206 0.56435 0.91057
Diluted Weighted Average Shares 45.0021 44.385 41.9297 39.0613 38.9216
Diluted EPS Excluding Extraordinary Items -0.19246 -0.1028 -0.02891 0.01445 0.02339
Diluted Normalized EPS -0.19246 -0.10282 0.00877 0.08432 0.0233
Total Extraordinary Items
Dividends per Share - Common Stock Primary Issue
Gain (Loss) on Sale of Assets 0 0.00101 0.01659 0.04783 0.00493
Unusual Expense (Income) 0 2.44721 3.41568
Other, Net 0 0.67991
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total revenue 7.39261 7.34468 7.7604 6.54663 6.24433
Revenue 7.39261 7.34468 7.7604 6.54663 6.24433
Cost of Revenue, Total 3.24557 3.26654 3.43804 3.20046 2.62203
Gross Profit 4.14704 4.07814 4.32236 3.34617 3.6223
Total Operating Expense 10.4494 9.8561 9.28988 10.1601 9.37085
Selling/General/Admin. Expenses, Total 5.42588 4.75992 4.82535 5.53002 5.49121
Research & Development 1.56487 1.64198 0.86215 1.30373 1.14836
Depreciation / Amortization 0.21312 0.18766 0.16434 0.12588 0.10925
Operating Income -3.05682 -2.51142 -1.52948 -3.61346 -3.12652
Interest Income (Expense), Net Non-Operating 0.12482 0.10003 0.03242 -0.01814 -0.0086
Gain (Loss) on Sale of Assets -0.05628 0 0 0 0
Net Income Before Taxes -2.98829 -2.41139 -1.49706 -3.6316 -3.13511
Net Income After Taxes -2.41089 -1.97673 -1.22556 -2.92134 -2.53751
Net Income Before Extra. Items -2.41089 -1.97673 -1.22556 -2.92134 -2.53751
Net Income -2.41089 -1.97673 -1.22556 -2.92134 -2.53751
Income Available to Common Excl. Extra. Items -2.41089 -1.97673 -1.22556 -2.92134 -2.53751
Income Available to Common Incl. Extra. Items -2.41089 -1.97673 -1.22556 -2.92134 -2.53751
Diluted Net Income -2.41089 -1.97673 -1.22556 -2.92134 -2.53751
Diluted Weighted Average Shares 45.4876 45.3762 45.0382 44.9219 44.668
Diluted EPS Excluding Extraordinary Items -0.053 -0.04356 -0.02721 -0.06503 -0.05681
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.0522 -0.04356 -0.02721 -0.06503 -0.05681
Unusual Expense (Income)
Other, Net
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 29.8016 37.3212 37.5258 11.8813 9.03305
Cash and Short Term Investments 17.4083 25.3349 27.3153 5.87093 5.25673
Cash & Equivalents 17.4083 25.3349 27.3153 5.87093 3.7388
Short Term Investments 0 1.51793
Total Receivables, Net 4.53128 4.31111 2.57295 3.23452 1.42585
Accounts Receivable - Trade, Net 3.55888 3.59289 2.57295 3.23452 1.42585
Total Inventory 6.40487 6.10634 6.82977 2.38848 2.10388
Prepaid Expenses 1.45723 1.56882 0.80778 0.3874 0.24659
Total Assets 42.3324 41.293 39.9189 13.8819 10.545
Property/Plant/Equipment, Total - Net 7.67352 1.202 1.40447 0.98558 0.85878
Intangibles, Net 0.78718 0.80881 0.84359 0.80714 0.63216
Other Long Term Assets, Total 4.07011 1.96107 0.14509 0.20782 0.02105
Total Current Liabilities 6.95894 4.79198 3.6664 2.40629 1.58423
Accounts Payable 2.3918 1.22753 0.62492 0.57266 0.4535
Accrued Expenses 3.77817 2.96586 3.03884 1.82834 1.12697
Notes Payable/Short Term Debt 0.4333 0.50858 0 0 0
Other Current Liabilities, Total 0.25734 0.09 0 0.00376
Total Liabilities 11.0065 4.79198 3.76196 2.64578 1.58423
Total Long Term Debt 0.39428 0 0 0.00265 0
Deferred Income Tax 0
Other Liabilities, Total 3.65326 0 0.09555 0.23685 0
Total Equity 31.326 36.5011 36.157 11.2361 8.96081
Common Stock 0.48862 0.48044 0.4668 0.4224 0.40933
Additional Paid-In Capital 44.2521 40.7743 35.881 6.29307 4.59521
Retained Earnings (Accumulated Deficit) -9.57121 -0.91007 3.65275 4.86482 4.30047
Treasury Stock - Common -3.84356 -3.84356 -3.84356 -0.3442 -0.3442
Total Liabilities & Shareholders’ Equity 42.3324 41.293 39.9189 13.8819 10.545
Total Common Shares Outstanding 45.4414 44.6237 43.2596 39.5026 38.1957
Property/Plant/Equipment, Total - Gross 10.4679 3.51403 3.39009 2.80482
Accumulated Depreciation, Total -2.7944 -2.31203 -1.98562 -1.81924
Current Port. of LT Debt/Capital Leases 0.09834 0 0.00265 0.0053
Capital Lease Obligations 0.39428 0 0.00265
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total Current Assets 25.2147 29.8016 30.7423 30.9683 33.9313
Cash and Short Term Investments 12.2249 17.4083 16.4413 18.2656 22.5772
Cash & Equivalents 12.2249 17.4083 16.4413 18.2656 22.5772
Total Receivables, Net 5.17927 4.53128 5.75619 4.76556 3.82547
Accounts Receivable - Trade, Net 4.16451 3.55888 5.07008 4.08476 3.1454
Total Inventory 6.63842 6.40487 6.88416 6.77151 6.01774
Prepaid Expenses 1.1721 1.45723 1.66066 1.16567 1.51085
Total Assets 38.254 42.3324 42.6658 42.4613 43.4276
Property/Plant/Equipment, Total - Net 7.61294 7.67352 7.51538 7.36317 6.07255
Property/Plant/Equipment, Total - Gross 9.8376 10.4679 10.166 9.86705 8.46595
Accumulated Depreciation, Total -2.22466 -2.7944 -2.65064 -2.50387 -2.39339
Intangibles, Net 0.78253 0.78718 0.79853 0.79178 0.79534
Other Long Term Assets, Total 4.64385 4.07011 3.6096 3.3381 2.62844
Total Current Liabilities 4.52422 6.95894 6.16749 5.73013 4.71262
Accounts Payable 1.50312 2.3918 1.36561 2.38986 1.26798
Accrued Expenses 2.44146 3.77817 3.73519 3.03327 3.0734
Notes Payable/Short Term Debt 0.2184 0.4333 0.64473 0 0.25561
Current Port. of LT Debt/Capital Leases 0.09969 0.09834 0.06447 0.0665
Total Liabilities 8.45768 11.0065 10.1741 9.83999 8.62654
Total Long Term Debt 0.36884 0.39428 0.26554 0.28196 0
Other Liabilities, Total 3.56462 3.65326 3.74102 3.8279 3.91392
Total Equity 29.7963 31.326 32.4917 32.6213 34.8011
Common Stock 0.48961 0.48862 0.48657 0.48408 0.48121
Additional Paid-In Capital 45.1324 44.2521 43.4432 42.3498 41.611
Retained Earnings (Accumulated Deficit) -11.9821 -9.57121 -7.59448 -6.36892 -3.44758
Treasury Stock - Common -3.84356 -3.84356 -3.84356 -3.84356 -3.84356
Total Liabilities & Shareholders’ Equity 38.254 42.3324 42.6658 42.4613 43.4276
Total Common Shares Outstanding 45.5403 45.4414 45.2365 44.9871 44.7008
Other Current Liabilities, Total 0.26154 0.25734 0.35749 0.2405 0.11563
Capital Lease Obligations 0.36884 0.39428 0.26554 0.28196
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -8.66114 -4.56282 -1.21206 0.56435 0.91057
Cash From Operating Activities -5.40455 -4.31951 -0.74332 0.32062 1.47966
Cash From Operating Activities 0.58714 0.46313 0.4186 0.34023 0.30926
Deferred Taxes -2.02623 -1.81598 0.06297 -0.18678 -0.02314
Non-Cash Items 3.29197 2.70655 2.92099 1.1484 0.2991
Cash Taxes Paid 0 0.0019 0.32198 0.13088 0.378
Cash Interest Paid 0.02849 0.01324 0.02774 0.00034 0
Changes in Working Capital 1.40371 -1.11038 -2.93381 -1.54558 -0.01613
Cash From Investing Activities -2.80157 -0.36617 -1.03615 1.31021 -1.72982
Capital Expenditures -2.80157 -0.37523 -1.06115 -0.42554 -0.48117
Other Investing Cash Flow Items, Total 0 0.00907 0.025 1.73575 -1.24866
Cash From Financing Activities 0.27949 2.70528 23.2238 0.5013 0.01443
Financing Cash Flow Items -0.07529 0.50858 0 -0.00282 -0.03682
Issuance (Retirement) of Stock, Net 0.40662 2.19935 23.2291 0.5089 0.05125
Net Change in Cash -7.92663 -1.9804 21.4444 2.13213 -0.23573
Issuance (Retirement) of Debt, Net -0.05185 -0.00265 -0.0053 -0.00478
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -2.41089 -8.66114 -6.68442 -5.45886 -2.53751
Cash From Operating Activities -4.66058 -5.40455 -6.74101 -4.62531 -1.75207
Cash From Operating Activities 0.21312 0.58714 0.39948 0.23513 0.10925
Deferred Taxes -0.5774 -2.02623 -1.57957 -1.30807 -0.5976
Non-Cash Items 0.932 3.29197 2.57913 1.57915 0.83756
Cash Taxes Paid 0 0 0 0 0
Cash Interest Paid 0.01233 0.02849 0.0157 0.0062 0.00443
Changes in Working Capital -2.81742 1.40371 -1.45564 0.32733 0.43623
Cash From Investing Activities -0.28384 -2.80157 -2.5777 -1.92883 -0.7526
Capital Expenditures -0.28384 -2.80157 -2.5777 -1.92883 -0.7526
Other Investing Cash Flow Items, Total 0 0 0 0
Cash From Financing Activities -0.23897 0.27949 0.42509 -0.51519 -0.25297
Issuance (Retirement) of Stock, Net 0.40662 0.314 0 0
Issuance (Retirement) of Debt, Net -0.02408 -0.05185 -0.02506 -0.00661 0
Net Change in Cash -5.18339 -7.92663 -8.89362 -7.06934 -2.75764
Financing Cash Flow Items -0.21489 -0.07529 0.13615 -0.50858 -0.25297

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Repro Med Systems, Inc. Company profile

About Repro-Med Systems, Inc.

Repro Med Systems, Inc. is a medical technology company, which is focused on the developing, manufacturing, and commercializing of specialty infusion solutions. The Company designs, manufactures, and markets medical devices, primarily for the ambulatory infusion market. Its development and marketing focus is primarily concentrated on its mechanical infusion products. The Company's products include the FREEDOM Infusion Systems, which consist of the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgHFlo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The FREEDOM System operates at a lower pressure and maintains a balance between what a patient’s subcutaneous tissues can absorb and what the system delivers. The Company performs product assembly, calibration, pre- and post-assembly quality control inspection and testing, and final packaging for all its products at its Chester, New York facility.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Repro-Med Systems, Inc. revenues decreased 3% to $23.5M. Net loss increased from $1.2M to $4.6M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Selling, general and administrative increase of 49% to $17.9M (expense), Research and development increase of 91% to $2.5M (expense).

Equity composition

Common Stock $.01 Par, 11/10, 50M auth., 38,811,667 issd., less 2,275,000 shs. in Treas. @ $142K. Insiders control approx. 27.87 .Public Offering 11/82, $4.8M shares @ $.25 by State Street Securities. Preferred Stock 8% Cumulative $.01 Par, 2M auth., 10,000 issd.

Industry: Medical Equipment, Supplies & Distribution (NEC)

100 Corporate Drive
MAHWAH
NEW JERSEY 07430
US

Income Statement

  • Annual
  • Quarterly

News

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

People also watch

ETH/USD

3,567.64 Price
+1.590% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

BTC/USD

70,819.35 Price
+2.860% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

US100

18,249.80 Price
-0.090% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

Gold

2,217.38 Price
+1.110% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 21:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading